{
    "clinical_study": {
        "@rank": "38752", 
        "brief_summary": {
            "textblock": "The purpose of this study is the use of Methylphenidate in the treatment of cocaine\n      dependence and Attention Deficit Hyperactivity Disorder (ADHD) comorbidity."
        }, 
        "brief_title": "Methylphenidate in the Treatment of Cocaine Dependent Patients With Adult Attention Deficit Hyperactivity Disorder - 5", 
        "condition": [
            "Cocaine-Related Disorders", 
            "Substance-Related Disorders"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Cocaine-Related Disorders", 
                "Substance-Related Disorders", 
                "Attention Deficit Disorder with Hyperactivity"
            ]
        }, 
        "detailed_description": {
            "textblock": "The objective of this study is to determine the safety and efficacy of methylphenidate in a\n      population of patients who are cocaine dependent and suffer from attention deficit\n      hyperactivity disorder."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n        Cocaine-dependent. Meets the DSM-IV criteria for ADHD. Actively using cocaine within the\n        past 30 days of screening.\n\n        Exclusion Criteria:\n\n        Symptoms of AIDS. Significant medical disorder. DSM-IV criteria for any substance other\n        than cocaine, alcohol, nicotine, marijuana, caffeine. Requires detoxification from ETOH or\n        benzos. History of seizures."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "50 Years", 
            "minimum_age": "21 Years"
        }, 
        "enrollment": "0", 
        "firstreceived_date": "April 18, 2001", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00015223", 
            "org_study_id": "NIDA-5-0013-5", 
            "secondary_id": "Y01-5-0013-5"
        }, 
        "intervention": {
            "intervention_name": "Methylphenidate", 
            "intervention_type": "Drug"
        }, 
        "intervention_browse": {
            "mesh_term": "Methylphenidate"
        }, 
        "lastchanged_date": "October 17, 2012", 
        "location": {
            "facility": {
                "address": {
                    "city": "Cincinnati", 
                    "country": "United States", 
                    "state": "Ohio"
                }, 
                "name": "Cincinnati MDRU"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "official_title": "Methyphendidate in the Treatment of Cocaine Dependent Patients With Adult ADHD", 
        "overall_official": {
            "affiliation": "U of Cincinnati", 
            "last_name": "Gene Somoza, M.D.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Federal Government"
        }, 
        "phase": "Phase 2", 
        "primary_outcome": [
            {
                "measure": "Cocaine use"
            }, 
            {
                "measure": "Methylphenidate retention"
            }, 
            {
                "measure": "Safety assessments"
            }, 
            {
                "measure": "Psychosocial counseling sessions"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00015223"
        }, 
        "source": "National Institute on Drug Abuse (NIDA)", 
        "sponsors": {
            "collaborator": {
                "agency": "Cincinnati MDRU", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "National Institute on Drug Abuse (NIDA)", 
                "agency_class": "NIH"
            }
        }, 
        "start_date": "June 1997", 
        "study_design": "Masking: Double-Blind, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "October 2012"
    }, 
    "geocoordinates": {
        "Cincinnati MDRU": "39.103 -84.512"
    }
}